Inflammatory cytokines such as IL6 (and IL8, IL1B) are implicated in GBM tumorigenicity and progression [70], and IL6 in particular leads to JAK-STAT pro-tumor signaling [71]. This evidence concerns the gene IL6 and glioblastoma.